Journal of Cancer Research | Volume 1(2) | 2023

Related Journals

View More

Recent Articles

Low Melatonin and Post COVID Syndrome: Unveiling SIBO as a Potential Pre Cancerous Condition in the Post-Pandemic Era
Exploring AminoSineTriComplex (AminoTriComplex) for Multimodal Tumor Management in Carcinogen-Induced Rat Models: Insights from Blood Biomarker Analysis
Ethical Principles Relevant to the Use of Aspirin as a Treatment of Cancer
The Effect of Soulager on Apoptosis, E-cadherin, and PTEN Modulation in Breast, NSCLC, and Prostate Cancer Cells
The Institute for Personalized Medicine in Georgia: A Hub of Scientific Innovation and Global Healthcare Leadership
Mapping the Metabolic Landscape of Lung Adenocarcinoma: From Energy Flexibility in Early Stages to Glycolytic Entrapment in Advanced Disease

View More

Share This Page

Volume 1(2), (2023)

Research Article

Atezolizumab Is a Humanized IGG1 Monoclonal Antibody That Targets PD-L1

Dhananjoy Saha, Dhrubo Jyoti Sen, Soumya Roy and Soumya Chakraborty

+1 234 695 123